Home > News > New IMI brochure ‘Carry the torch’ highlighting impacts of IMI projects

New IMI brochure ‘Carry the torch’ highlighting impacts of IMI projects

01/11/2017

IMI projects are accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. Furthermore, some of our projects are already delivering direct benefits to patients. Interested in concrete numbers and examples? Find out more about the impact and outputs of IMI projects in our the new brochure, and learn how IMI is 'Carrying the torch for medical innovation'.

Download the brochure ''Carrying the torch for medical innovation' as PDF.


The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. IMI does this by facilitating collaboration between the key players involved in healthcare research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world's biggest public-private partnership (PPP) in the life sciences. It is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). Through the IMI2 programme, we have a €3.3 billion budget for the period 2014-2020. The HARMONY Alliance is funded through IMI.

Read more at: www.imi.europa.eu